A Response to: Letter to the Editor Regarding "Comparing Cardiovascular Outcomes and Costs of Perindopril-, Enalapril- or Losartan-Based Antihypertensive Regimens in South Africa: Real-World Medical Claims Database Analysis"
Adv Ther. 2024 Nov 19.
doi: 10.1007/s12325-024-03045-y.
Online ahead of print.
2 Department of Statistical Sciences, University of Cape Town, Cape Town, South Africa.
3 Division of Nephrology and Hypertension, Department of Medicine, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa.
4 Health Economics Unit, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.
5 Division of Cardiology, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand and the Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa.
6 Quantium Health South Africa, Johannesburg, South Africa.
7 Division of Cardiology, Department of Medicine, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa. [email protected].
8 Cape Heart Institute, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa. [email protected].
9 South African Medical Research Council, Parow Valley, Cape Town, South Africa. [email protected].
10 African Research Universities Alliance/The Guild of European Research Intensive Universities Cluster of Research Excellence on Noncommunicable Diseases and Associated Multimorbidity, Brussels, Belgium. [email protected].